-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
- Neuphoria Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $3,253,615.
- Neuphoria Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $1,528,276, a 90% decline from 2024.
- Neuphoria Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $15,108,794, a 292% increase from 2023.